Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 50-75 between age patients~* ASA status III patients~* patients undergoing coronary artery bypass graft operation~Exclusion Criteria:~* cardiomyopathy,~* arrhythmia,~* valvular disease,~* electrolyte disorders~* chronic liver and kidney diseases~* use of medication that led to extended QT intervals

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Control group(Group C) (Type: NO_INTERVENTION): After pre-oxygenation, anesthesia induction will be performed with intravenous administration of 2 μg / kg fentanyl, 2 mg/kg propofol, 0.6 mg/kg rocuronium bromide (Esmeron 5 mg vial, Organon Oss Holanda).
- Group L (Type: OTHER): The induction of group L will be performed 5 minutes after administration of 10% topical lidocaine (Lidocaine pump spray 10% 50 ml) 160 mg (16 puffs) application

Based on this trial design, predict the completion outcome and termination type (if applicable).